4//SEC Filing
Guerin Mark Patrick 4
Accession 0001415889-23-009750
CIK 0001130598other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:54 PM ET
Size
8.6 KB
Accession
0001415889-23-009750
Insider Transaction Report
Form 4
Guerin Mark Patrick
Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2023-06-12$1.14/sh−1,575$1,791→ 22,116 total - Exercise/Conversion
Restricted Stock Units
2023-06-12−5,500→ 11,000 total→ Common Stock (5,500 underlying) - Exercise/Conversion
Common Stock
2023-06-12+5,500→ 23,691 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001607714
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:54 PM ET
- Size
- 8.6 KB